Home > Boards > US OTC > Biotechs >

Aethlon Medical, Inc. (AEMD)

AEMD RSS Feed
Add AEMD Price Alert      Hide Sticky   Hide Intro
Moderator: mick, uber darthium
Search This Board: 
Last Post: 8/4/2020 9:11:10 PM - Followers: 226 - Board type: Free - Posts Today: 0



$AEMD this should get ah few upticks !!!!!

ree;

Fourth Quarter & Fiscal Year End 2020 Investor Call
Jun 25, 2020 • 4:15pm EDT
Interested parties can register for the conference by navigating to http://dpregister.com/10145174. Please note that registered participants will receive their dial in number upon registration.

Interested parties without internet access or unable to pre-register may dial in by calling:

PARTICIPANT DIAL IN (TOLL FREE): 1-844-836-8741
PARTICIPANT INTERNATIONAL DIAL IN: 1-412-317-5442
All callers should ask for the Aethlon Medical, Inc. conference call.
$AEMD FILINGS AND DISCLOSURE
OTC Disclosure & News
https://www.otcmarkets.com/stock/AEMD/disclosure
 
ActiveInactiveAll
PUBLISH DATE TITLE PERIOD END DATE STATUS
05/20/2015 OTCQB Certification - OTCQB Certification 03/31/2014 A
Displaying 1 of 1 Disclosure & News
SEC Filings
FORM TYPE RECEIVED PERIOD END DATE REPORT
4 04/07/2020 04/03/2020 PDFRTFHTMLXLS
4 04/07/2020 04/03/2020 PDFRTFHTMLXLS
4 04/07/2020 04/03/2020 PDFRTFHTMLXLS
4 04/07/2020 04/03/2020 PDFRTFHTMLXLS
4 04/07/2020 04/03/2020 PDFRTFHTMLXLS
4 04/02/2020 03/31/2020 PDFRTFHTMLXLS
4 04/02/2020 03/31/2020 PDFRTFHTMLXLS
4 04/02/2020 03/31/2020 PDFRTFHTMLXLS
4 04/02/2020 03/31/2020 PDFRTFHTMLXLS
EFFECT 03/31/2020 PDFRTFHTML
replay of the call will be available approximately one hour after the end of the call through July 2, 2020. The replay can be accessed by dialing 1-877-344-7529 (domestic) or 1-412-317-0088 (international) or Canada Toll Free at 1-855-669-9658. The replay conference ID number is 10145174.



AEMD, NO LONGER

SUSPENDED BY

THE SECURITIES AND

EXCHANGE COMMISSION 

03-25-2020, Aethlon Announces Issuance of European Patent for the Hemopurifier® in Cancer
March 25, 2020 Leave a comment 355 Views

https://www.exosome-rna.com/aethlon-announces-issuance-of-european-patent-for-the-hemopurifier-in-cancer/

Aethlon Announces Issuance of European Patent for the Hemopurifier® in Cancer
Posted by: Exosome RNA Administrator in Industry News, Patents, Press Releases March 25, 2020 0 356 Views

Aethlon Medical, Inc, a therapeutic medical device and technology company focused on unmet needs in global health, announced today

That it has received European Patent No. 1,993,600
(“the ‘600 Patent”) entitled “Extracorporeal Removal of Microvesicular Particles.”

The ‘600 patent embodies Aethlon’s Hemopurifier® technology designed
for the depletion of immune suppressive, and potentially cancer-promoting, exosomes from the circulatory system.






https://www.aethlonmedical.com/about



 SITE FOR HOW MANY INFECTED;
 https://www.worldometers.info/coronavirus/Coronavirus
  https://www.worldometers---POPULATION
  
https://www.worldometers.info/
 

 Combating Infectious Disease and Cancer with Immunotherapeutic Technologies

  At Aethlon Medical, we are a leading developer of immunotherapeutic technologies to combat infectious disease and cancer. To augment the body's natural immune defenses,
  the Aethlon Hemopurifier® eliminates life-threatening disease targets that are often shielded from the immune system and not well addressed by traditional drug therapies.

  The technology captures circulating viruses, bacterial toxins and cancer promoting exosomes through affinity attachment to a unique structure  cloaks these targets from immune detection.

  At present, the Hemopurifier® is being advanced under an FDA approved clinical study. Aethlon is also the majority owner of Exosome Sciences, Inc.,
  a company focused on the discovery of exosomal biomarkers to diagnose and monitor life-threatening diseases.

  Diagnosing and Monitor Life-Threatening Diseases

   Exosome Sciences, Inc., in collaboration with majority shareholder Aethlon Medical,
   is focused on the discovery of exosomal biomarker candidates to diagnose and monitor life-threatening diseases.
   The proprietary Enzyme-Linked Lectin-Specific Assay (ELLSA™) serves as a platform to isolate exosomal biomarkers from a wide-range of bodily fluids.

   In preliminary studies, ELLSA™ demonstrated the ability to isolate exosomes from urine, which resulted in high-sensitivity detection of HIV-infection.
   Specific to neurological disorders, Exosome Sciences discovered TauSome™, an exosomal biomarker that may be the first non-invasive candidate to
   detect Chronic Traumatic Encephalopathy (CTE) in living individuals. In a study of former National Football League (NFL) players,
   TauSome levels were found to be significantly higher as compared to athlete control subjects who participated in non-contact sports.
   TauSome levels also correlated with cognitive decline based standardized tests of memory and psychomotor speed. Visit www.exosomesciences.com for additional details.
 

    May 18, 2017

   The Treatment of the Ebola Virus

    Time Magazine named the Hemopurifier® a "Top 25 Invention" and a "Remarkable Advance in Healthcare" based on its use in treating Ebola virus.
 

    We’re Developing Medical Countermeasures with Broad-Spectrum Capabilities

     Supporting an initiative set by the U.S. Department of Health and Human Services

      Emerging pathogens pose a significant threat to mankind. Of the hundreds of viral pathogens known to be infectious to man, only a few are addressed with
      proven antiviral drug or vaccine therapies. Beyond the looming threat of bioterrorism, a proliferation of international travel, urban crowding and global warming
      is expected to accelerate the emergence of future pandemics. In response, the U.S. Department of Health and Human Services (HHS) has established an initiative
      to support platform technology medical countermeasures with broad-spectrum capabilities. Based on preclinical studies and human treatment experiences, the Aethlon Hemopurifier® defines this initiative. 

     Administered to individuals infected with Ebola, Hepatitis C and HIV

      To date, Hemopurifier therapy has been administered to individuals infected with Ebola virus, Hepatitis C virus (HCV) and the Human Immunodeficiency virus (HIV).
      In the case of Ebola, a remarkable response to a single administration of Hemopurifier therapy (comatose physician with multiple organ failure at the time), led to
      Time Magazine naming the Hemopurifier to be one of the "Top 25 Inventions" as well as one of the "Eleven Most Remarkable Advances in Healthcare."

     Status of clinical studies

      Beyond human treatment experiences, pre-clinical Hemopurifier studies have validated the broad-spectrum capture of numerous viral threats.
      These include: Chikungunya, Dengue and West Nile virus, as well as Vaccinia and Monkey pox, which serve as models for human Smallpox infection.

      Specific to pandemic influenza threats, Aethlon has validated the capture of H5N1 avian flu, H1N1 swine flu, and the reconstructed 1918 influenza virus,
      which represents a model for the strain of influenza that killed an estimated 50 million victims in 1918 and 1919. In vitro studies of other viral threats are ongoing.
 
    https://coronavirus.jhu.edu/map.html
   
 

    

================================================================================================================================================================================
================================================================================================================================================================================
================================================================================================================================================================================                                                   
                                                                                                                        

     


 *DISCLAIMER *The Board Monitor and The Board Assistants herewith, are not licensed brokers and assume NO responsibility for the actions, investment decisions, and or messages posted on this forum.
• We do NOT recommend that anyone buy or sell any securities posted herewith. Any trade entered into risks the possibility of losing the funds invested.
• There are no guarantees when buying or selling any security.





 

 

 


 

AEMD
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
News News Alert: Aethlon Medical Announces Collaboration with University of Pittsburgh on NIH Grant for Head and Neck Cancer 08/06/2020 08:00:00 AM
PostSubject
#17779  Sticky Note $AEMD 06-18-2020 Aethlon Announces FDA Approval of IDE mick 06/20/20 04:11:33 PM
#16426  Sticky Note So far Aethion isn't even in the Coronavirus Jimmy Joe 02/10/20 12:35:14 AM
#17977   Surprised you found that. Thanks for providing link. millman 08/04/20 09:11:10 PM
#17976   $AEMD https://srch.eurekalert.org/e3/query.html?col=ev3new&col=ev3oneyr&col=ev3r mick 08/03/20 08:41:19 PM
#17975   $AEMD Aethlon Medical Inc (AEMD) mick 07/26/20 12:40:50 PM
#17974   $AEMD United States Coronavirus Cases:4,338,288,Deaths:149,589 mick 07/26/20 12:38:27 PM
#17973   $AEMD Coronavirus Cases:16,308,119,Deaths:650,148,Recovered:9,969,197 mick 07/26/20 12:33:30 PM
#17972   Aethlon Medical Inc (AEMD) mick 07/26/20 12:09:56 PM
#17971   Thanks for info. Mick. Hholding above $2 millman 07/26/20 09:02:29 AM
#17970   $United States Coronavirus Cases:4,290,235,Deaths:149,046 mick 07/25/20 03:48:23 PM
#17969   $AEMD $Coronavirus Cases:16,087,202,Deaths:645,309,Recovered:9,827,717 mick 07/25/20 03:47:45 PM
#17968   $AEMD Aethlon Medical Inc (AEMD) mick 07/25/20 02:36:17 PM
#17967   An update from AEMD would be nice - millman 07/24/20 06:38:16 PM
#17966   This and GOVX are biggest covid19 total failures.. Trompete 07/23/20 02:13:24 PM
#17965   This company is a real big joke... Trompete 07/23/20 12:22:46 AM
#17964   $AEMD AETHLON STOCK INSTITUTIONAL HOLDERS mick 07/21/20 11:00:40 PM
#17963   $AEMD Aethlon Medical (AEMD) is traded on BATS mick 07/21/20 11:00:06 PM
#17962   $AEMD Strong Buy1 Opinion mick 07/21/20 10:58:15 PM
#17961   $AEMD AETHLON MEDICAL PROFILE mick 07/21/20 10:57:26 PM
#17960   $AEMD AEMD -- USA Stock mick 07/21/20 10:56:51 PM
#17959   Up nicely again today! BDD 07/21/20 08:36:00 AM
#17958   Nice uptick today so far! BDD 07/20/20 01:57:13 PM
#17957   $AEMD https://www.toppennystockmovers.com/stock-ticker/?symbols=aemd&submit=Tick mick 07/16/20 04:48:55 PM
#17956   I'm tired of winning trading AEMD. This is pennysoldier 07/16/20 03:51:06 PM
#17955   Company is a joke. You had a chance Harbor6460 07/16/20 01:54:21 PM
#17954   Monroe1 - thanks, appreciate it. millman 07/15/20 04:25:28 PM
#17953   If AEMD would stop diluting shares into the millman 07/13/20 08:07:51 PM
#17952   uch findings have implications for vaccine development, since millman 07/13/20 08:05:45 PM
#17951   But two new scientific studies have discovered that millman 07/13/20 08:02:56 PM
#17950   $AEMD HMMM. mick 07/09/20 07:42:55 PM
#17949   $AEMD THIS IS USUALLY HAPPENS A.H. OR PRE-MARKET mick 07/09/20 07:41:37 PM
#17948   I sold out at a good profit. Will Monroe1 07/09/20 06:57:12 PM
#17947   wow, strong volume. Any news? Something big is Monroe1 07/09/20 06:52:24 PM
#17946   Aethlon Medical Inc (AEMD) mick 07/09/20 06:27:48 PM
#17945   $AEMD NEWS ????? a.h. strong upticks !!!!! mick 07/09/20 06:27:33 PM
#17944   Lol, sorry, not this stock, but the idea Trompete 07/09/20 02:19:11 PM
#17943   But it isn't the science. It is the Trompete 07/09/20 02:18:21 PM
#17942   This is the worst junk stock ive ever Harbor6460 07/09/20 02:15:38 PM
#17941   Yep. Buy CTSO years ahead of this company. Harbor6460 07/08/20 10:43:17 PM
#17940   Prepare for dilution and next 3 years of Trompete 07/05/20 03:08:56 AM
#17939   I am long and strong. I found this Monroe1 07/02/20 04:21:44 PM
#17938   So go buy it and adios. We like Monroe1 07/02/20 04:04:33 PM
#17937   That would exclude you Trompete 07/02/20 04:01:14 PM
#17936   Think so? BAyyyaaauaaaaa hhhh hahaha. Real Science wins Monroe1 07/02/20 04:00:39 PM
#17935   Buahahahah, just imagine, yeah, just keep the dilusion Trompete 07/02/20 02:37:43 PM
#17934   100% rite. You want sales...you want a Real Harbor6460 07/01/20 11:23:39 PM
#17933   Correction: Aethlon Medical's Net Loss Narrows in Fiscal Monroe1 07/01/20 06:09:46 PM
#17932   Yes, it will be worth it. Just imagine Monroe1 07/01/20 06:04:26 PM
#17931   $AEMD great read revs !!!!! mick 07/01/20 05:14:15 PM
#17930   oh really? whats the $AEMD new offering? SpotOnTrade 07/01/20 03:37:38 PM
#17929   With offering sure, offering is coming with big steps Trompete 07/01/20 03:34:00 PM
#17928   Hardly, the contract/grant revenue make this company worth uber darthium 07/01/20 03:08:48 PM
PostSubject